Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	18.05	-17.32	-21.14
Graham Fair Price	-2.32	3.10	3.17
PEG	inf	0.00	-0.16
Price/Book	-26.77	0.10	0.13
Price/Cash Flow	inf	0.00	181.29
Prices/Earnings	27.99	-4.60	-6.39
Price/Sales	74505.41	780.75	1.05
Price/FCF	inf	0.00	181.29
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	764.48	0.21	0.02
Operating Margin	-75869.27	-43.29	-0.06
ROA	-6.02	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-1.69
ROIC	< 0.005	< 0.005	11.73
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.00	0.00	0.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.21	0.00	inf
EPS QOQ	0.41	0.00	inf
FCF QOQ	1.07	0.00	inf
Revenue QOQ	-0.46	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Not Interpreted

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.00	0.00	0.00
Quick Ratio	0.64	0.04	-94.03
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	9.35	9.05	-3.13
Cash	1.24	0.06	-95.58
Capex	< 0.005	n.A.	n.A.
Free Cash Flow	< 0.005	n.A.	n.A.
Revenue	1.17	< 0.005	-99.90
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	5.78	7.25	25.45
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.24	1.17	397.32
Naive Interpretation	Member

06 - Financial Health · Bad

Rating